Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 8, pp. 2172-2182
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 3, 2008
- Revision received May 4, 2009
- Accepted June 3, 2009
- Published first August 11, 2009.
Article Versions
- Previous version (August 11, 2009 - 08:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Lori Rink1,
- Yuliya Skorobogatko1,
- Andrew V. Kossenkov1,
- Martin G. Belinsky1,
- Thomas Pajak2,
- Michael C. Heinrich3,
- Charles D. Blanke4,
- Margaret von Mehren1,
- Michael F. Ochs5,
- Burton Eisenberg6 and
- Andrew K. Godwin1
- 1Department of Medical Oncology, Fox Chase Cancer Center, and 2Radiation Therapy Oncology Group, Philadelphia, Pennsylvania; 3Oregon Health and Science University, Portland, Oregon; 4University of British Columbia and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 5The Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland; and 6Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
- Requests for reprints:
Andrew K. Godwin, Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. Phone: 215-728-2756; Fax: 215-728-2741. E-mail: Andrew.Godwin{at}fccc.edu
Note: L. Rink and Y. Skorobogatko contributed equally to this work.
August 2009
Volume 8, Issue 8
Volume 8, Issue 8
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
Jump to section
Advertisement